What is the reported valuation and current status of Apollo Global Management's potential acquisition of Johnson & Johnson's orthopedics unit?

According to Bloomberg News, Apollo Global Management is in talks to acquire Johnson & Johnson's orthopedics unit—DePuy Synthes—at a valuation close to $20 billion; the report states that an agreement could be reached within weeks, though Reuters could not verify it and neither Apollo nor J&J responded to requests for comment.

Why is Johnson & Johnson considering separating its orthopedics unit, and what are its key products and recent financial performance?

J&J announced last year it plans to separate its orthopedics unit, DePuy Synthes, into a standalone company within 18 to 24 months to sharpen focus on higher-growth healthcare segments; the unit manufactures hip, knee and shoulder implants, surgical instruments and other products, and generated $9.3 billion in sales in 2025.

Apollo Global in talks to acquire J&J's orthopedics unit, Bloomberg News reports

Sep 11, 2026

Apollo Global Management is reportedly in talks to acquire Johnson & Johnson's orthopedics unit, DePuy Synthes, in a deal valued near $20 billion. The unit, which generated $9.3 billion in sales last year, was previously slated for separation by J&J.

reuters

2026-09-11

Apollo Global in talks to acquire J&J's orthopedics unit, Bloomberg News reports

FAQ

Scan to get the App